Second Genome Strengthens R&D Program in Immuno-Oncology with Four Academic Collaborations
Second Genome, Inc., a leader in the development of novel medicines derived from the human microbiome, today announced the initiation of four collaborations with key academic institutions to evaluate the effect of gut microbiota on […]